Endo International Plc News

J&J, Other Drugmakers Go to Trial in California in $50B Case Over ‘Deadly Legacy’ of Opioids

Four drugmakers helped cause the deadly U.S. opioid epidemic by deceptively marketing their drugs and downplaying their addictive risks, a lawyer for several California counties argued on Monday at the start of a multibillion-dollar trial. Those counties accuse Johnson & …

Endo to Rework $3.3 Billion Loan as Opioid Litigation Looms

Endo International Plc is trying to get more breathing room on its debt as it contests with ongoing opioid and patent litigation and an expected drop in earnings. The drug company said it will issue new debt to refinance its …

New York Charges Teva, Allergan With Insurance Fraud Over Opioid Claims

NEW YORK — New York state filed civil charges on Tuesday accusing Teva Pharmaceutical Industries Ltd and Allergan Plc with insurance fraud for downplaying the risks of their opioid painkillers to patients and doctors. Governor Andrew Cuomo said the charges …

New York Charges Drugmaker Endo with Insurance Fraud Over Opioid Claims

New York state filed civil charges on Wednesday accusing Endo International Plc of insurance fraud for misrepresenting the safety and efficacy of its opioid drugs, adding fuel to the nation’s opioid crisis. Governor Andrew Cuomo said the charges brought by …

J&J Avoids Risky Opioid Trial With ‘Chump Change’ Ohio Deal

Johnson & Johnson agreed to pay more than $20 million to avoid the first federal trial in which it faced accusations of helping fuel the opioid epidemic by mishandling its painkillers. Under the deal, announced late Tuesday, J&J will pay …

Opioid Trial Judge Denies He’s Biased, Refuses to Step Down

The Cleveland judge overseeing more than 2,000 federal lawsuits over alleged opioid abuses refused to disqualify himself from a bellwether trial set to start next month, rejecting a request by drug distributors and pharmacies who say he is biased against …